Activation of Hodgkin cells via the CD30 receptor induces autocrine secretion of interleukin-6 engaging the NF-κB transcription factor

Blood

Volumn 87, Issue 6, 1996, Pages 2443-2449

  Gruss, Hans Jürgen ^a   Ulrich, Dawn ^b   Dower, Steven K ^b   Herrmann, Friedhelm ^b   Brach, Marion A ^b  

^a Section of Pathology   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MESSENGER RNA; TRANSCRIPTION FACTOR;

ARTICLE; CONTROLLED STUDY; HODGKIN DISEASE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN SECRETION; RNA ANALYSIS; SIGNAL TRANSDUCTION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD30; BASE SEQUENCE; CYTOKINES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; GROWTH HORMONE; HODGKIN DISEASE; HUMANS; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NF-KAPPA B; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; REED-STERNBERG CELLS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029869285     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Schwab U, Stein H, Gerdes J, Lemke H, Kirchner H, Schaadt M, Diehl V: Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 299:65, 1982
2. Hecht TT, Longo DL, Cossman J, Bolen JB, Hsu SM, Israel M, Fisher RI: Production and characterization of a monoclonal antibody that binds Reed-Sternberg cells. J Immunol 134:4231, 1985
3. Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lemke H, Schwarting R, Lennett K: The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:848, 1985
4. Schwarting R, Gerdes J, Dürkop H, Falini B, Pileri S, Stein H: Ber-H2: A new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood 74:1678, 1989
5. Drexler HG: Recent results on the biology of Hodgkin and Reed-Sternberg cells. I. Biopsy material. Leuk Lymphoma 8:283, 1992
6. Herbst H, Stein H, Niedobitek G: Epstein-Barr virus and CD30+ malignant lymphomas. Crit Rev Oncogene 4:191, 1993
7. Grass H-J, Herrmann F: CD30 ligand a member of the TNF-ligand superfamily with growth and activation control for CD30+ lymphoid and lymphoma cells. Leuk Lymphoma 18:179, 1995
8. Falini B, Pileri S, Pizzoolo G, Dürkop H, Flenghi L, Stirpe F, Martelli M, Stein H: CD30 (Ki-1) molecule: A new cytokine receptor of the tumor necrosis factor receptor family as a tool for diagnosis and immunotherapy. Blood 85:1, 1005
9. Dürkop H, Latza U, Hummel M, Eitelbach F, Seed B, Stein H: Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68:421, 1992
10. Gruss H-J, Dower SK: Tumor necrosis factor ligand superfamily: Involvement in the pathology of malignant lymphomas. Blood 85:3378, 1995
11. Smith DA, Gruss H-J, Davis T, Andersond D, Farrah T, Baker E, Sutherland GR, Brannan CI, Copeland NG, Jenkins NA, Grabstein KH, Gliniak B, McAlister IB, Fanslow W, Alderson M, Faalk B, Gimpel S, Gillis S, Din WS, Goodwin RG, Armitage RJ: CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73:1349, 1993
12. Gruss H-J, Boiani N, Williams DE, Armitage RJ, Smith CA, Goodwin RG: Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood 83:2045, 1994
13. Gruss H-J, Hirschstein D, Alderson MR, Herrmann F, Armitage RJ: Regulation of CD30 ligand expression on peripheral blood T-cells: Possible functional involvement in T-T-cell interaction. J Immunol (in press)
14. Gruss H-J, Ulrich D, Braddy S, Armitage RJ, Dower SK: Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Sternberg cells. Eur J Immunol 25:2083, 1995
15. Delabie J, Ceuppens JL, Vandenberghe P, de Boer M, Coorevits L, De Wolf-Peeters C: The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin's disease and contributes to the stimulating capacity of Hodgkin's disease-derived cell lines. Blood 82:2845, 1993
16. Munro JM, Freedman AS, Aster JC, Gribben JG, Lee NC, Rhynhart KK, Banchereau J, Nadler LM: In vivo expression of the B7 costimulatory molecule by subsets of antigen-presenting cells and malignant cells of Hodgkin's disease. Blood 83:793, 1994
17. Ruco LP, Pomponi D, Pigott R, Gearing AJ, Baiocchini A, Baroni CD: Expression and cell distribution of the intercellular adhesion molecule, vascular cell adhesion molecule, endothelial leukocyte adhesion molecule, and endothelial ceil adhesion molecule (CD31) in reactive human lymph nodes and in Hodgkin's disease. Am J Pathol 140:1337, 1992
18. Pfreundschuh M, Pohl C, Berenbeck C, Schroeder J, Jung W, Schmits R, Tschiersch A, Diehl V, Gause A: Detection of a soluble form of CD30 antigen in sera of patients with lymphoma, adult T-cell leukemia and infectious mononucleosis. Int J Cancer 45:869, 1990
19. Pizzolo G, Vinante F, Chilosi M, Dallenbach F, Josimovic-Alasevic O, Diamantstein T, Stein H: Serum levels of soluble CD30 molecule (Ki-1 antigen) in Hodgkin's disease: Relationship with disease activity and clinical stage. Br J Haematol 75:282, 1990
20. Gause A, Pohl C, Tschiersch A, Da Costa L, Jung W, Diehl V, Hasenclever D, Pfreundschuh M: Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease. Blood 77:1983, 1991
21. Nadali G, Vinante F, Ambrosetti A, Todeschini G, Veneri D, Zanotti R, Meneghini V, Ricetti MM, Fiacchini M, Stein H, Pizzolo G: Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosis. J Clin Oncol 12:793, 1994
22. Gruss H-J, Brach MA, Drexler HG, Bonifer R, Mertelsmann RH, Herrmann F: Expression of cytokine genes, cytokine receptor genes, and transcription factors in cultured Hodgkin and Reed-Sternberg cells. Cancer Res 52:3353, 1992
23. Kurzrock R, Redman J, Cabanillas F, Jones D, Rothberg J, Talpaz M: Serum-interleukin-6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms. Cancer Res 53:2118, 1993
24. Gruss H-J, Dölken G, Brach MA, Mertelsmann R, Herrmann F: The significance of serum levels of soluble 60 kDa receptor for tumor necrosis factor in patients with Hodgkin's disease. Leukemia 7:1339, 1993
25. Gruss H-J, Herrmann F, Drexler HG: Hodgkin's disease: A cytokine producing tumor. Crit Rev Oncogenesis 5:23, 1994
26. Gause A, Scholz R, Klein S, Jung W, Diehl V, Tesch H, Hasenclever D, Pfreundschuh M: Increased levels of circulating interleukin-6 in patients with Hodgkin's disease. Hematol Oncol 9:307, 1991
27. Brach MA, Gruss H-J, Kaisho T, Asano Y, Mertelsmann R, Hirano T, Herrmann F: Ionizing radiation induces interleukin 6 transcription involving activation of the nuclear factor kappa B. J Biol Chem 268:8466, 1993
28. Gruss H-J, Brach MA, Herrmann F: Involvement of nuclear factor-kappa B in induction of the interleukin-6 gene by leukemia inhibitory factor. Blood 80:2563, 1992
29. Liebermann TA, Baltimore D: Activation of the interleukin-6 gene expression through the NF-kB transcription factor. Mol Cell Biol 10:2327, 1990
30. Sha WC, Liou H-C, Tuomanen EI, Baltimore D: Targeted disruption of the p50 subunit of NF-kB leads to multifocal defects in immune responses. Cell 80:321, 1995
31. Weih FCD, Durham SK, Barton DS, Rizzo CA, Ryseck RP, Lira SA, Bravo R: Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kB/Rel family. Cell 80:331, 1995
32. Jücker M, Abts H, Li W, Schindler R, Merz H, Günther A, von Kalle C, Schaadt M, Diamantstein T, Feller AC, Krueger GRF, Diehl V, Blankenstein T, Tesch H: Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease. Blood 77:2413, 1991
33. Foss HD, Herbst H, Oelmann E, Samol J, Grebe M, Blankenstein T, Matthes J, Quin Z, Falini B, Pileri S, Stein H: Lymphotoxin, tumor necrosis factor and interleukin 6 gene transcripts are present in Hodgkin and Reed Sternberg cells of most Hodgkin's disease cases. Br J Haematol 84:627, 1993
34. Tesch H, Jücker M, Klein S, Abts H, Gunther A, Krueger GR, Diehl V: Hodgkin- and Reed Sternberg cells express interleukin 6 and interleukin 6 receptors. Leuk Lymphoma 7:297, 1992
35. Isshiki H, Akira S, Tanake O, Nakajuma T, Shimamoto T, Hirano T, Kishimoto T: Constitutive and IL-1 inducible factors interact with the EL-1 responsive element in the IL-6 gene. Mol Cell Biol 10:2757, 1990
36. Smith CA, Farrah T, Goodwin RG: The TNF-receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 75:959, 1994
37. Wiegmann K, Schütze S, Machleidt T, Witte D, Krönke M: Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78:1005, 1994
38. Tartaglia LA, Ayres TM, Wong G, Goeddel DV: A novel domain within the 55 kd TNF receptor signals cell death. Cell 74:845, 1993
39. Rothe M, Wong SC, Henzel WJ, Goeddel DV: A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78:681, 1994
40. Cheng G, Cleary MA, Ye ZS, Hong DI, Lederman S, Baltimore D: Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267:1494, 1995
41. Hu HM, O'Rourke K, Boguski MS, Dixit VM: A novel ring finger protein interacts with the cytoplasmic domain of CD40. J Biol Chem 269:30069, 1994
42. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E: The Epstein-barr virus transforming protein LMP-1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389, 1995
43. Rothe M, Sarma V, Dixit VM, Goeddel DV: TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269:1424, 1995
44. Bäuerle PA, Henkel T: Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12:141, 1994